The five-year survival rate for people diagnosed with the most advanced stage of non-small cell lung cancer (NSCLC) is pretty grim, only between one and 10 percent. To address this devastating condition, the Board of the California Institute for Regenerative Medicine (CIRM) today voted to invest almost $12 million in a team from UCLA that … Continue reading CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence
ICOC Board Meetings
Budgeting for the future of the stem cell agency
Budgets are very rarely exciting things; but they are important. For example, it’s useful for a family to know when they go shopping exactly how much money they have so they know how much they can afford to spend. Stem cell agencies face the same constraints; you can’t spend more than you have. Last week … Continue reading Budgeting for the future of the stem cell agency
March ICOC/Governing Board Meeting Begins Soon
The March ICOC/Governing Board Meeting is beginning this morning at 9am in Berkeley, CA. Agenda details and dial-in instructions can be found on our website. Please watch this space for an update from the meeting. You can also keep up with the latest news by visiting CIRM on Twitter and Facebook.
January ICOC Board Meeting To Begin Soon
The January ICOC Board Meeting begins this morning in San Francisco, CA. The complete agenda and dial-in instructions can be found here. Stay tuned for updates after the meeting!